No Detail Found!

Significance of molecular analysis in a population screening program for identification of silent beta thalassemia carriers in a country with high disease prevalence

Author(s)
Rija Tariq INMOL Hospital,Lahore, Pakistan
Nada Sikandar Indus Hospital & Health Network, Jubilee Town Lahore, Pakistan
Samia Akhtar BSL-111 Labs Primary & Secondary Health Care Department, Lahore, Pakistan
Shabnam Bashir Department of Pathology, Fatima Jinnah Medical University, Pakistan
Muhammad Umar Farooq Demonstrator Biostatistics, Institute of Public Health, Lahore, Pakistan
Abstract
Objective: The objective of this study is to establish the importance of molecular analysis in such individuals and its significance in a population screening program. Methodology: This descriptive cross-sectional study was conducted by the Punjab Thalassemia Prevention Project during a period of 1 year from July 2020 to June 2021. A total of 67 individuals suspected to be silent Beta Thalassemia carriers were tested by the multiplex amplification refractory mutation system-Polymerase Chain Reaction to identify underlying mutations. Independent samples Ttest was used to compare the RBC indices and HbA2 values of subjects with and without underlying mutations taking P value <0.05 as statistically significant. Results: Of the individuals tested, 73% (n=49) had underlying Beta Thalassemia mutations. CAP+1 (n=30, 61%) was the most common mutation identified followed by IVS1-5 (n=12, 25%). Subjects with a mutation displayed a significantly lower mean corpuscular volume and mean corpuscular haemoglobin than those without mutation (P = 0.002 and 0.003 respectively). The mean HbA2 in the subjects with mutation was 3.4% vs mean of 3.2% for those without an underlying mutation (P = 0.011).The mean MCV and MCH of CAP+1 mutation was higher when compared to the other mutations identified. Conclusions: Molecular analysis should be offered to all those individuals who have borderline HbA2, carrier spouse and/or suggestive family history for identification of silent carriers and effective disease prevention.
Publication Details
Page(s) 68-72
DOI DOI not available
Published Journal: Journal of Haematology and Stem Cell Research, Volume: 2, Issue: 2, Year: 2022

Request the full text from PASTIC

Keywords
Silent carriers, CAP 1 mutation., Silent carriers, Beta Thalassaemia Major, Beta Thalassaemia Major, Beta Thalassaemia Major, Beta Thalassaemia Major, Molecular testing, Molecular testing, Molecular testing, Molecular testing
0

Citations

0

Downloads

19

Views